-
Sadras, T, Jalud, FB, Kosasih, HJ, Horne, CR, Brown, LM, El-Kamand, S, de Bock, CE, McAloney, L, Ng, AP, Davidson, NM, et al.
Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL.
Leukemia
37(4)
:
905 -909
2023
view publication
-
Laetsch, TW, Maude, SL, Rives, S, Hiramatsu, H, Bittencourt, H, Bader, P, Baruchel, A, Boyer, M, De Moerloose, B, Qayed, M, et al.
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Journal of Clinical Oncology
41(9)
:
1664 -1669
2023
view publication
-
Carpenter, PA, Kang, HJ, Yoo, KH, Zecca, M, Cho, B, Lucchini, G, Nemecek, ER, Schultz, KR, Stepensky, P, Chaudhury, S, et al.
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
Transplantation and Cellular Therapy
28(11)
:
771.e1 -771.e10
2022
view publication
-
Venn, NC, Huang, L, Hovorková, L, Muskovic, W, Wong, M, Law, T, Heatley, SL, Khaw, SL, Revesz, T, Dalla Pozza, L, et al.
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
British Journal of Cancer
127(5)
:
908 -915
2022
view publication
-
Brown, LM, Hediyeh-zadeh, S, Sadras, T, Huckstep, H, Sandow, JJ, Bartolo, RC, Kosasih, HJ, Davidson, NM, Schmidt, B, Bjelosevic, S, et al.
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
Blood Advances
6(7)
:
2373 -2387
2022
view publication